SSC Stenographer Admit Card 2017

TESARO trades as part of the healthcare sector and is in the biotechnology industry. The company CEO is Leon O. Moulder. Tesaro Inc is an oncology-focused biopharmaceutical company. It focuses on developing treatments for cancer.



Previous Intraday Performance:

The TSRO shares had a previous change of 0.03% which opened at 74.94 and closed at 74.96. It moved to an intraday high of 74.97 and a low of 74.94.

SeekingAlpha:  Biotech Forum: What To Watch In The Week Ahead

Historical Performance:

Over the last five trading days, TSRO shares returned 0.21% and in the past 30 trading days it returned 1.60%. Over three months, it changed 103.03%. In one year it has changed 9.88% and within that year its 52 week high was 75.16 and its 52 week low was 23.41. TSRO stock is 220.21% above its 52 week low.

Our calculations result in a 200 day moving average of 45.95 and a 50 day moving average of 60.25. Right now, TSRO stock is trading 63.12% above its 200 day moving average.

SeekingAlpha:  Biotech Forum: What To Watch In The Week Ahead

Liquidity:

The company has a market cap of $4.1b with 55.1m shares outstanding and a float of 53.1m shares. Trading volume was 1,183,517 shares and has experienced an average volume of 3,211,216 shares. Our calculation, using the current average volume and close price, leads me to believe that the liquidity is good.

Earnings:

The last annual reported EPS for TESARO was -9.19 which ended on 31st of December 2017. Based on 9 analyst estimates, the consensus EPS for the next quarter is -2.45.

Below was the last reported quarterly diluted earnings per share:

3rdQtr 2018Reported 11-01-2018: -2.49
2ndQtr 2018Reported 08-02-2018: -3.04
1stQtr 2018Reported 05-03-2018: -2.98
4thQtr 2017Reported 02-27-2018: -3.35
3rdQtr 2017Reported 11-07-2017: -0.47

Base on our calculations, the intrinsic value per share is 41.69, which means it might be overvalued by -79.80%.

The long-term trend of the EPS is an important number as it indicates the present value of TESARO; the EPS growth rate, as it is typically called, is usually expressed as a percentage, which at this time is hard to estimate, but revenue growth has been 20.90% over the last twelve months.



Indicators Also to Watch:

Based on the latest filings, there is 3.50% of insider ownership and 162.20% of institutional ownership.

The beta was calculated to be 0.40.

SeekingAlpha:  Textainer Group Holdings Limited 2019 Q1 – Results – Earnings Call Slides

Fundamental Numbers:

Based on last reported financials, the company’s return on assets is -92.89%, price-to-sales is 24.24 and price-to-book is 16.25.

Company Score Card:

Results are out of six:
 5  : Growth Expectations Result
 3  : Financial Safety Result
 0  : Past Performance Result
 0  : Valuation Result
 0  : Dividend Safety Result
 2  : Overall Result

Related Tags: , , ,

Jake McWilliams
I am an independent trader, analyst and algorithmic trading expert, having worked both for the sell side (brokerage) and the buy side (fund administration). I have been trading professionally for about 20 years. I trade stocks and forex and I play both long and short positions in underlying asset or through options. I have experience with discretionary and fully automated systems (Metatrader and Quantshare).

LEAVE A REPLY

Please enter your comment!
Please enter your name here